To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCNYTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
602 supporting clones for gene CCNY back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB494616 hypothalamus .a 1 to 498 1 to 501   tiling clone,   501/508
(98 %)
9 diff
(98.3 %id)
DB501186 hypothalamus .a 12 to 514 1 to 504   tiling clone,   504/504
(100 %)
9 diff
(98.3 %id)
AF413522   .a 353 to 1868 1 to 1520 S155C I171M V216A S268F tiling clone,   1520/1723
(88 %)
19 diff
(98.9 %id)
AY504868   .a 353 to 1868 1 to 1520 S155C I171M V216A S268F     1520/1723
(88 %)
19 diff
(98.9 %id)
NM_145012.4   .a 353 to 4305 1 to 3953 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3953/3953
(100 %)
0 diff
(100 %id)
AW340726 pooled .a 412 to 1102 1 to 691     Submitted on the opposite strand 691/691
(100 %)
9 diff
(98.7 %id)
DR001103 fetal brain .a 453 to 1182 9 to 737       729/745
(97 %)
9 diff
(98.8 %id)
EL953518 eyeball .a 466 to 988 1 to 525       525/539
(97 %)
10 diff
(98.2 %id)
CR991779 T-Lymphocytes .a 472 to 1225 1 to 754       754/754
(100 %)
5 diff
(99.4 %id)
AL834355 brain .a 506 to 2608 12 to 2113 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2102/2102
(100 %)
3 diff
(99.9 %id)
BP195096 brain .a 508 to 1088 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BC094815 Brain, neuroblastoma .a 508 to 2115 8 to 1615 exact tiling clone, AAA   1608/1615
(99 %)
8 diff
(99.6 %id)
BQ883183 brain, neuroblastoma, cell line .a 508 to 1377 7 to 876       870/876
(99 %)
12 diff
(98.7 %id)
CD359628 testis .a 525 to 1348 1 to 831   available from MGC,   812/878
(92 %)
31 diff
(96.5 %id)
BC069224 testis .a 527 to 2130 1 to 1604 exact tiling clone, available from MGC, AAA   1604/1604
(100 %)
2 diff
(99.9 %id)
AF465729   .a 532 to 2120 1 to 1589 Y118H AAA   1589/1589
(100 %)
3 diff
(99.9 %id)
BG291008 bladder, transitional cell papilloma, cell line .a 536 to 1282 1 to 741       741/923
(80 %)
22 diff
(97.7 %id)
AV683384 hepatocellular carcinoma .a 559 to 925 1 to 358       362/358
(101 %)
10 diff
(97.3 %id)
AW579496 head_neck .a 630 to 866 237 to 1       237/238
(99 %)
2 diff
(99.2 %id)
BI829247 brain, medulla .b 1 to 927 1 to 925   tiling clone,   925/928
(99 %)
23 diff
(97.6 %id)
TI_57176166   .b 1 to 927 30 to 954       925/957
(96 %)
29 diff
(97.0 %id)
BC104773 Brain, cerebellum, PCR rescued clones .b 397 to 1402 35 to 1040 exact     1006/1040
(96 %)
6 diff
(99.5 %id)
BC104801 Brain, cerebellum, PCR rescued clones .b 397 to 1401 35 to 1039 exact     1005/1039
(96 %)
6 diff
(99.5 %id)
BC143455 Brain, cerebellum, PCR rescued clones .b 397 to 1411 35 to 1049 exact tiling clone,   1015/1049
(96 %)
6 diff
(99.5 %id)
TI_1241108753   .b 397 to 1413 1056 to 42 exact tiling clone, Submitted on the opposite strand 1015/1208
(84 %)
4 diff
(99.7 %id)
TI_1241108759   .b 397 to 1261 94 to 957     Submitted on the opposite strand 864/1211
(71 %)
8 diff
(99.4 %id)
TI_1241112849   .b 397 to 1413 1062 to 46 exact   Submitted on the opposite strand 1017/1238
(82 %)
1 diff
(100.0 %id)
TI_1241113233   .b 397 to 1402 96 to 1093 R264D S265P A266R R267G K268A ...   Submitted on the opposite strand 998/1228
(81 %)
20 diff
(98.4 %id)
TI_1241108757   .b 397 to 1409 1057 to 46 exact   Submitted on the opposite strand 1012/1224
(82 %)
5 diff
(99.6 %id)
TI_1241108763   .b 397 to 1389 93 to 1072 A230R N231T N232T L233*   Submitted on the opposite strand 980/1144
(85 %)
24 diff
(98.0 %id)
TI_1241112877   .b 397 to 1409 1062 to 50 exact   Submitted on the opposite strand 1013/1249
(81 %)
2 diff
(99.9 %id)
TI_1241113261   .b 397 to 1402 98 to 1095 E243R R244G A245L H246T K247S ...   Submitted on the opposite strand 998/1248
(79 %)
21 diff
(98.4 %id)
TI_2194576214   .b 397 to 1419 1072 to 51 exact   Submitted on the opposite strand 1022/1276
(80 %)
7 diff
(99.5 %id)
TI_2194576595   .b 397 to 1412 94 to 1103 K258S Y259T K260R D261T L262*   Submitted on the opposite strand 1010/1276
(79 %)
14 diff
(99.0 %id)
TI_2194576782   .b 397 to 1419 1067 to 45 exact   Submitted on the opposite strand 1023/1228
(83 %)
6 diff
(99.6 %id)
TI_2194576792   .b 397 to 1409 94 to 1101 E243R R244G A245L H246T K247S ...   Submitted on the opposite strand 1008/1208
(83 %)
17 diff
(98.6 %id)
TI_2194576797   .b 397 to 1382 95 to 1077 K260N R264D S265P A266R R267G ...   Submitted on the opposite strand 983/1228
(80 %)
13 diff
(99.0 %id)
BC050310 Brain, hippocampus .c 1 to 3715 1 to 3712 I90F F91* tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 3712/3713
(99 %)
11 diff
(99.8 %id)
BI551304 brain, hippocampus .c 3 to 886 8 to 891   tiling clone, available from MGC,   884/985
(89 %)
26 diff
(97.4 %id)
TI_44170056   .c 3 to 812 89 to 894       806/1066
(75 %)
23 diff
(97.9 %id)
TI_154035071   .c 2191 to 3178 50 to 1025     Submitted on the opposite strand 976/1068
(91 %)
32 diff
(97.1 %id)
BG164629 hypernephroma, cell line, Kidney .c 2202 to 2967 1 to 757       757/959
(78 %)
29 diff
(97.0 %id)
BM547937 brain, hippocampus .c 2216 to 3250 20 to 1061       1042/1066
(97 %)
18 diff
(98.4 %id)
BF970592 adrenal cortex carcinoma, cell line, adrenal gland .c 2226 to 2979 24 to 779       756/846
(89 %)
29 diff
(96.6 %id)
N24292 melanocyte .c 2227 to 2684 1 to 471       471/471
(100 %)
15 diff
(96.9 %id)
BM549133 melanotic melanoma, skin .c 2233 to 3220 1 to 999   AAA   999/1027
(97 %)
21 diff
(98.0 %id)
AU253868 neuroblastoma .c 2233 to 2882 1 to 648       648/648
(100 %)
24 diff
(96.3 %id)
W73117 heart .c 2234 to 2836 1 to 596       596/603
(98 %)
20 diff
(96.7 %id)
DA812273 ovary, tumor tissue .c 2254 to 3032 2 to 781   capped   780/780
(100 %)
4 diff
(99.5 %id)
BM894186 insulinoma, Pancreas .c 2269 to 2823 1 to 555     Submitted on the opposite strand 555/555
(100 %)
0 diff
(100 %id)
CK824103 insulinoma, Pancreas .c 2269 to 2858 1 to 590     Submitted on the opposite strand 590/590
(100 %)
0 diff
(100 %id)
BU782693 insulinoma, Pancreas .c 2269 to 2749 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
D82669   .c 2282 to 2674 1 to 398       398/398
(100 %)
17 diff
(95.8 %id)
BP421100 small intestine .c 2291 to 2792 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
T36116 testis .c 2293 to 2587 1 to 295       295/295
(100 %)
0 diff
(100 %id)
AW958757   .c 2294 to 2904 1 to 607       607/613
(99 %)
23 diff
(96.3 %id)
AW958764   .c 2294 to 2899 1 to 607       607/607
(100 %)
7 diff
(98.9 %id)
BU941093 mixed (pool of 40 RNAs) .c 2297 to 3104 1 to 813       813/814
(99 %)
19 diff
(97.7 %id)
TI_149306283   .c 2300 to 2964 754 to 91   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 664/963
(68 %)
2 diff
(99.8 %id)
BU686337 lung, Primary Lung Epithelial Cells .c 2300 to 2964 682 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 664/672
(98 %)
2 diff
(99.8 %id)
N23812.
matches multiple genes
melanocyte .c 2304 to 2797 1 to 513     also hits gene HMGN4 513/514
(99 %)
27 diff
(94.8 %id)
BG036466 adenocarcinoma, cell line, Prostate .c 2317 to 3029 1 to 707       707/825
(85 %)
11 diff
(98.7 %id)
CR738572 carcinoid, lung .c 2332 to 2623 1 to 296       296/296
(100 %)
7 diff
(97.7 %id)
BE546360 cervical carcinoma cell line, cervix .c 2332 to 3047 1 to 706       706/708
(99 %)
22 diff
(96.9 %id)
AA167089   .c 2337 to 2841 1 to 500       500/542
(92 %)
8 diff
(98.6 %id)
CD671770 eye, Iris .c 2347 to 2859 1 to 513   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
TI_151728541   .c 2351 to 3241 954 to 80   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 875/934
(93 %)
25 diff
(97.4 %id)
TI_154106421   .c 2363 to 3172 881 to 73   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 809/972
(83 %)
6 diff
(99.4 %id)
BM850247 stomach .c 2369 to 2711 1 to 343       343/343
(100 %)
0 diff
(100 %id)
CA446806 Chondrosarcoma, Left Pubic Bone .c 2402 to 3172 784 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 771/771
(100 %)
2 diff
(99.8 %id)
R47794 breast .c 2408 to 2707 1 to 306       306/406
(75 %)
9 diff
(97.8 %id)
W93614 heart .c 2421 to 2627 1 to 206     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 206/206
(100 %)
4 diff
(98.1 %id)
DN916787   .c 2426 to 2551 127 to 1       127/127
(100 %)
4 diff
(96.9 %id)
BI554210 anaplastic oligodendroglioma with 1p/19qloss, brain .c 2453 to 3246 810 to 18     Submitted on the opposite strand 793/812
(97 %)
0 diff
(100 %id)
TI_44384896   .c 2453 to 3246 856 to 64     Submitted on the opposite strand 793/812
(97 %)
0 diff
(100 %id)
AW967423   .c 2455 to 3157 1 to 699       699/699
(100 %)
6 diff
(99.2 %id)
AA237046 germinal center B cell .c 2455 to 2975 1 to 520     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 520/520
(100 %)
1 diff
(99.9 %id)
CB959240 Pooled-Glandular .c 2472 to 3204 1 to 748       748/750
(99 %)
28 diff
(96.3 %id)
CA443082 Fibrosarcoma .c 2479 to 3241 776 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 758/758
(100 %)
5 diff
(99.4 %id)
AI333733 lung .c 2483 to 2963 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BM747598 stomach .c 2492 to 2974 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
CA419612 Bone, Human Chondrosarcoma Cell Line .c 2520 to 3241 740 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 722/722
(100 %)
0 diff
(100 %id)
AA011285 heart .c 2521 to 2964 447 to 1       447/448
(99 %)
3 diff
(99.4 %id)
R11703 whole brain .c 2528 to 2917 1 to 393     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 393/393
(100 %)
5 diff
(98.8 %id)
R12119 whole brain .c 2528 to 2872 1 to 347     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 347/446
(77 %)
6 diff
(98.7 %id)
AA827358 Kidney, kidney tumor .c 2552 to 2964 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
BQ026909 Chondrosarcoma, Left Pubic Bone .c 2569 to 3241 691 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
BQ181264 Knee, Osteoarthritic Cartilage .c 2569 to 3241 691 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
BG426631 Kidney .c 2576 to 3404 1 to 838       838/895
(93 %)
36 diff
(96.0 %id)
BQ774838 Bone, Human Chondrosarcoma Cell Line .c 2581 to 3241 679 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 661/661
(100 %)
0 diff
(100 %id)
BG536524 lung .c 2582 to 3276 1 to 685       685/689
(99 %)
15 diff
(97.9 %id)
AA962416 carcinoid, lung .c 2592 to 2963 372 to 1       372/372
(100 %)
0 diff
(100 %id)
BQ009604 Chondrosarcoma, Left Pubic Bone .c 2599 to 3241 661 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
BM996053 lung, Metastatic Chondrosarcoma .c 2609 to 3241 652 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 634/634
(100 %)
1 diff
(99.9 %id)
CA429453 Cell Line, Chondrosarcoma .c 2609 to 3241 651 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 633/633
(100 %)
0 diff
(100 %id)
FN078542 breast carcinoma .c 2618 to 2722 98 to 1     Submitted on the opposite strand 98/100
(98 %)
7 diff
(93.0 %id)
BU159499 eye, retinoblastoma .c 2630 to 3435 12 to 818   tiling clone,   807/821
(98 %)
6 diff
(99.3 %id)
AI766065 Kidney .c 2634 to 3241 608 to 1       608/608
(100 %)
2 diff
(99.7 %id)
BM894459 insulinoma, Pancreas .c 2694 to 3229 543 to 8     Submitted on the opposite strand 536/543
(98 %)
0 diff
(100 %id)
BU783687 insulinoma, Pancreas .c 2695 to 3229 542 to 8     Submitted on the opposite strand 535/542
(98 %)
0 diff
(100 %id)
BF000011 colon, colon tumor, RER+ .c 2702 to 3241 567 to 27   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 541/541
(100 %)
5 diff
(99.1 %id)
BE220307 carcinoid, lung .c 2704 to 3240 537 to 1       537/537
(100 %)
0 diff
(100 %id)
AW204723   .c 2712 to 3241 547 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
BG485132 lung .c 2723 to 3244 1 to 533       533/750
(71 %)
22 diff
(97.1 %id)
AW134790   .c 2724 to 3241 534 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 517/517
(100 %)
2 diff
(99.7 %id)
BE045653 carcinoid, lung .c 2724 to 3241 518 to 1       518/518
(100 %)
1 diff
(99.9 %id)
BI004444 head_normal .c 2725 to 3143 422 to 1       422/422
(100 %)
21 diff
(95.1 %id)
AI703437 carcinoid, lung .c 2729 to 3240 510 to 1       510/510
(100 %)
6 diff
(98.9 %id)
AI887668 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2729 to 3248 522 to 2       521/522
(99 %)
0 diff
(100 %id)
BE326554 carcinoid, lung .c 2729 to 3240 512 to 1       512/512
(100 %)
0 diff
(100 %id)
BE503949 carcinoid, lung .c 2738 to 3240 504 to 2       503/504
(99 %)
0 diff
(100 %id)
BP398193 pancreatic islet .c 2744 to 3241 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
AI870323 anaplastic oligodendroglioma, brain .c 2745 to 3241 497 to 1       497/497
(100 %)
1 diff
(99.8 %id)
AW173366 pooled .c 2745 to 3241 497 to 1       497/497
(100 %)
2 diff
(99.6 %id)
BE467812 carcinoid, lung .c 2745 to 3243 499 to 1       499/499
(100 %)
0 diff
(100 %id)
DB491305 hypothalamus .c 2747 to 3107 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
AW612648 carcinoid, lung .c 2757 to 3242 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AA135737 uterus .c 2761 to 3241 506 to 13   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 494/497
(99 %)
17 diff
(96.6 %id)
BF447632 carcinoid, lung .c 2761 to 3248 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BE218271 carcinoid, lung .c 2764 to 3244 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BE219630 carcinoid, lung .c 2764 to 3240 477 to 1       477/477
(100 %)
0 diff
(100 %id)
H98724 melanocyte .c 2804 to 3241 440 to 1       440/440
(100 %)
2 diff
(99.6 %id)
AI268864 carcinoid, lung .c 2804 to 3248 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AW189836 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2806 to 3245 440 to 1       440/440
(100 %)
3 diff
(99.4 %id)
H25442 breast .c 2816 to 3220 410 to 1       410/410
(100 %)
9 diff
(97.9 %id)
AI273393 adenocarcinoma, colon .c 2816 to 3248 434 to 2       433/434
(99 %)
0 diff
(100 %id)
AV705374 adrenal gland .c 2823 to 3179 1 to 357       357/361
(98 %)
3 diff
(99.2 %id)
FN152510 breast carcinoma .c 2824 to 2911 1 to 87       87/88
(98 %)
2 diff
(97.8 %id)
AI278947 adenocarcinoma, colon .c 2824 to 3248 426 to 2       425/426
(99 %)
0 diff
(100 %id)
AA806738 germinal center B cell .c 2825 to 3241 422 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 412/413
(99 %)
0 diff
(100 %id)
AI589281 adenocarcinoma, Pancreas .c 2825 to 3243 419 to 1       419/419
(100 %)
0 diff
(100 %id)
CD671769 eye, Iris .c 2829 to 3241 430 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 413/413
(100 %)
1 diff
(99.8 %id)
AI860721 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 2839 to 3244 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AA836448 germinal center B cell .c 2842 to 3248 419 to 13       407/419
(97 %)
0 diff
(100 %id)
AA505574 breast .c 2844 to 3241 398 to 1       398/398
(100 %)
0 diff
(100 %id)
H97021 melanocyte .c 2849 to 3241 393 to 1       393/394
(99 %)
2 diff
(99.5 %id)
H97049 melanocyte .c 2853 to 3241 392 to 1       392/392
(100 %)
3 diff
(99.3 %id)
W93402 heart .c 2854 to 3241 401 to 12   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 390/395
(98 %)
2 diff
(99.5 %id)
AW466921 2 pooled tumors (clear cell type), Kidney .c 2859 to 3237 390 to 12       379/390
(97 %)
0 diff
(100 %id)
FN121319 breast carcinoma .c 2863 to 2970 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
BU943800 mixed (pool of 40 RNAs) .c 2864 to 3242 1 to 379       379/380
(99 %)
2 diff
(99.5 %id)
AI699130 carcinoid, lung .c 2866 to 3240 374 to 1       374/375
(99 %)
6 diff
(98.4 %id)
N36243 melanocyte .c 2873 to 3241 369 to 1       369/369
(100 %)
4 diff
(99.0 %id)
AI367284 Kidney .c 2880 to 3247 372 to 5       368/372
(98 %)
0 diff
(100 %id)
AA911230 pooled .c 2883 to 3246 364 to 1       364/364
(100 %)
0 diff
(100 %id)
TI_149270949   .c 2886 to 3716 888 to 56   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 833/1016
(81 %)
69 diff
(93.3 %id)
D25619   .c 2889 to 3244 1 to 356     Submitted on the opposite strand 356/356
(100 %)
0 diff
(100 %id)
AA594325 colon, colon tumor RER+ .c 2897 to 3241 372 to 28   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 345/345
(100 %)
8 diff
(97.7 %id)
BG779150 adenocarcinoma, Prostate .c 2901 to 3645 1 to 747       747/747
(100 %)
2 diff
(99.8 %id)
AA858127 adenocarcinoma, colon .c 2915 to 3241 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AA976353 2 pooled tumors (clear cell type), Kidney .c 2917 to 3241 338 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 325/325
(100 %)
0 diff
(100 %id)
AI370017   .c 2924 to 3244 321 to 1       321/321
(100 %)
0 diff
(100 %id)
AW150562 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2936 to 3242 308 to 1       308/308
(100 %)
1 diff
(99.7 %id)
N22469 cochlea, ear .c 2939 to 3242 304 to 1       304/304
(100 %)
0 diff
(100 %id)
AI823318 Kidney .c 2951 to 3241 291 to 1       291/292
(99 %)
2 diff
(99.4 %id)
T39737 fetal spleen, Spleen .c 2957 to 3241 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
T39745 fetal spleen, Spleen .c 2957 to 3174 1 to 218       218/218
(100 %)
4 diff
(98.2 %id)
T39763 fetal spleen, Spleen .c 2957 to 3247 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
T39771 fetal spleen, Spleen .c 2957 to 3243 1 to 287       287/287
(100 %)
3 diff
(99.0 %id)
T39764 fetal spleen, Spleen .c 2957 to 3203 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
T39788 fetal spleen, Spleen .c 2957 to 3224 1 to 268       268/268
(100 %)
1 diff
(99.7 %id)
T39778.
matches multiple genes
fetal spleen, Spleen .c 2957 to 3226 1 to 269     Suspected internal deletion, this clone was ignored, also hits gene suwaha 269/269
(100 %)
1 diff
(99.7 %id)
AW594422 pooled germ cell tumors .c 2958 to 3248 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AI873655 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2962 to 3241 286 to 2       285/286
(99 %)
0 diff
(100 %id)
TI_149270775   .c 2966 to 3716 834 to 92   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 743/977
(76 %)
20 diff
(98.0 %id)
R50427 breast .c 2994 to 3241 258 to 1       258/259
(99 %)
16 diff
(93.9 %id)
AA857399 adenocarcinoma, colon .c 2996 to 3248 253 to 1       253/253
(100 %)
0 diff
(100 %id)
CA443527 lung, Metastatic Chondrosarcoma .c 3041 to 3241 219 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 201/201
(100 %)
5 diff
(97.6 %id)
BE621983 melanotic melanoma, skin .c 3064 to 3711 1 to 645       645/646
(99 %)
6 diff
(99.1 %id)
BQ014589 Chondrosarcoma, Left Pubic Bone .c 3067 to 3840 784 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 769/779
(98 %)
11 diff
(98.6 %id)
CB122527 Liver .c 3085 to 3172 1 to 88   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 88/88
(100 %)
0 diff
(100 %id)
BQ188900 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 3085 to 3714 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
TI_151733689   .c 3085 to 3718 729 to 96       634/1031
(61 %)
0 diff
(100 %id)
BU677083 lung, Primary Lung Epithelial Cells .c 3087 to 3241 173 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 155/155
(100 %)
1 diff
(99.4 %id)
AA034960.
matches multiple genes
uterus .c 3094 to 3241 148 to 1     also hits gene MAP7D1 148/153
(96 %)
0 diff
(100 %id)
BM723635 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 3113 to 3836 1 to 724       724/724
(100 %)
5 diff
(99.4 %id)
TI_151727660   .c 3123 to 3843 804 to 84       721/804
(89 %)
0 diff
(100 %id)
BU673964 lung, Primary Lung Epithelial Cells .c 3125 to 3716 610 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 592/592
(100 %)
2 diff
(99.7 %id)
AA236848 germinal center B cell .c 3127 to 3241 147 to 33   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 115/115
(100 %)
2 diff
(98.3 %id)
EC482120 Prostate .c 3144 to 3240 97 to 1       97/101
(96 %)
0 diff
(100 %id)
AI765014 Kidney .c 3164 to 3716 551 to 1       551/551
(100 %)
4 diff
(99.3 %id)
AI686101 Prostate .c 3179 to 3716 553 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 538/538
(100 %)
5 diff
(99.1 %id)
BE972816 testis .c 3179 to 3660 1 to 478       478/764
(62 %)
12 diff
(98.5 %id)
AW973707   .c 3185 to 3715 531 to 1     Submitted on the opposite strand 531/532
(99 %)
0 diff
(100 %id)
BG403234 bladder, transitional cell papilloma, cell line .c 3209 to 3716 25 to 530   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 506/530
(95 %)
7 diff
(98.7 %id)
BU674095 lung, Primary Lung Epithelial Cells .c 3220 to 3716 514 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 497/497
(100 %)
1 diff
(99.8 %id)
BE549749 carcinoid, lung .c 3223 to 3718 501 to 6       496/501
(99 %)
0 diff
(100 %id)
AA649254 germinal center B cell .c 3228 to 3716 509 to 21   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 489/489
(100 %)
0 diff
(100 %id)
BE966445 leiomyosarcoma, uterus .c 3234 to 3716 523 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 665/772
(86 %)
89 diff
(88.5 %id)
DB552538 hippocampus .c 3248 to 3714 1 to 468     Submitted on the opposite strand 468/470
(99 %)
3 diff
(99.4 %id)
BI862314 breast, mammary adenocarcinoma, cell line .c 3256 to 3716 1 to 461   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 461/461
(100 %)
1 diff
(99.8 %id)
TI_57191871   .c 3256 to 3716 92 to 552   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 461/461
(100 %)
1 diff
(99.8 %id)
W73137 heart .c 3277 to 3847 573 to 7       567/681
(83 %)
0 diff
(100 %id)
DB371617 ovary, tumor tissue .c 3291 to 3857 567 to 1   tiling clone,   567/583
(97 %)
9 diff
(98.5 %id)
AI620754 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 3292 to 3717 426 to 1       426/426
(100 %)
0 diff
(100 %id)
BF108373 carcinoid, lung .c 3293 to 3716 435 to 12   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
AA554886 breast .c 3331 to 3716 386 to 1       386/386
(100 %)
0 diff
(100 %id)
BE078013 breast .c 3344 to 3669 11 to 338       328/338
(97 %)
6 diff
(98.3 %id)
DB561767 hypothalamus .c 3345 to 3714 1 to 371     Submitted on the opposite strand 371/373
(99 %)
18 diff
(95.2 %id)
R61854 whole brain .c 3363 to 3718 372 to 7       366/392
(93 %)
0 diff
(100 %id)
T40782 fetal spleen, Spleen .c 3387 to 3714 329 to 2       328/329
(99 %)
0 diff
(100 %id)
T40776 fetal spleen, Spleen .c 3392 to 3714 324 to 2       323/324
(99 %)
0 diff
(100 %id)
N25594 melanocyte .c 3400 to 3846 452 to 1       452/452
(100 %)
7 diff
(98.5 %id)
R17680 whole brain .c 3417 to 3716 313 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 303/327
(92 %)
11 diff
(96.7 %id)
C21522   .c 3420 to 3725 1 to 318       318/321
(99 %)
33 diff
(89.8 %id)
R36873 whole brain .c 3434 to 3716 295 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 285/287
(99 %)
2 diff
(99.4 %id)
AA725795   .c 3438 to 3716 291 to 12       280/291
(96 %)
0 diff
(100 %id)
T40768.
matches multiple genes
fetal spleen, Spleen .c 3442 to 3714 274 to 2     also hits gene sterbyby 273/274
(99 %)
0 diff
(100 %id)
T40775 fetal spleen, Spleen .c 3593 to 3714 123 to 2       122/123
(99 %)
0 diff
(100 %id)
AF429969   .d 1 to 1759 1 to 1754 exact     1754/1761
(99 %)
12 diff
(99.4 %id)
AK057280 testis .d 1 to 1754 1 to 1754 I136V N196S tiling clone, available from FLJ,   1754/1754
(100 %)
2 diff
(99.9 %id)
NM_181698.2   .d 1 to 3933 1 to 3933 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 3933/3933
(100 %)
0 diff
(100 %id)
DB020588 testis .d 2 to 562 2 to 562   capped   561/569
(98 %)
1 diff
(99.9 %id)
DB040532 testis .d 2 to 323 2 to 323   capped   322/553
(58 %)
6 diff
(99.0 %id)
DB055259 testis .d 2 to 558 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DB021444 testis .d 5 to 319 2 to 316   capped   315/546
(57 %)
4 diff
(99.3 %id)
DB040697 testis .d 5 to 567 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB037730 testis .d 6 to 565 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB038948 testis .d 6 to 561 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DB041333 testis .d 14 to 562 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BI828601 brain, medulla .d 25 to 990 1 to 972       972/997
(97 %)
31 diff
(96.9 %id)
TI_57175300   .d 25 to 990 31 to 1002       972/1027
(94 %)
37 diff
(96.4 %id)
DB022980 testis .d 25 to 323 2 to 300   capped   299/551
(54 %)
7 diff
(98.8 %id)
DB056593 testis .d 31 to 567 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
TI_2194576184   .d 276 to 1221 1004 to 59 exact   Submitted on the opposite strand 946/1276
(74 %)
1 diff
(100.0 %id)
TI_2194576565   .d 276 to 1221 61 to 1006 exact   Submitted on the opposite strand 946/1281
(73 %)
7 diff
(99.5 %id)
TI_2194576781   .d 276 to 1221 1000 to 55 exact   Submitted on the opposite strand 946/1225
(77 %)
1 diff
(100.0 %id)
TI_2194576791   .d 276 to 1221 59 to 1004 exact   Submitted on the opposite strand 946/1219
(77 %)
9 diff
(99.3 %id)
TI_2194576796   .d 276 to 1221 61 to 1005 exact   Submitted on the opposite strand 945/1218
(77 %)
8 diff
(99.4 %id)
BC143450 Brain, cerebellum, PCR rescued clones .d 279 to 1220 1 to 942 exact     942/942
(100 %)
0 diff
(100 %id)
DC325602 caudate nucleus .d 304 to 783 98 to 576       479/576
(83 %)
10 diff
(98.3 %id)
DC332677 hippocampus .d 304 to 742 99 to 536       438/552
(79 %)
9 diff
(98.4 %id)
BI666529 brain, hypothalamus .d 304 to 1039 106 to 836       731/837
(87 %)
13 diff
(98.5 %id)
TI_44342720   .d 304 to 1039 190 to 920       731/921
(79 %)
13 diff
(98.6 %id)
BG723664 testis .d 306 to 742 311 to 748       438/762
(57 %)
10 diff
(98.7 %id)
BI828927 brain, medulla .d 306 to 737 284 to 719       436/720
(60 %)
16 diff
(97.8 %id)
TI_57172743   .d 306 to 737 312 to 747       436/748
(58 %)
16 diff
(97.9 %id)
BG193298   .d 312 to 1070 1 to 765       765/815
(93 %)
22 diff
(97.4 %id)
BQ304893 breast .d 314 to 562 275 to 29       249/489
(50 %)
1 diff
(99.8 %id)
BG255413 adenocarcinoma, cell line, Prostate .d 314 to 904 123 to 709       587/777
(75 %)
15 diff
(98.1 %id)
BU158677 large cell carcinoma, lung .d 314 to 1004 79 to 777       699/951
(73 %)
25 diff
(97.4 %id)
TI_2194576786   .d 317 to 1221 956 to 55 F3S N4M P5S S6D D7H ...   Submitted on the opposite strand 902/1148
(78 %)
4 diff
(99.7 %id)
TI_2194576787   .d 317 to 1228 954 to 45 P5R P9R F15S L16S S17V ...   Submitted on the opposite strand 910/1164
(78 %)
9 diff
(99.3 %id)
BG188042   .d 321 to 1059 49 to 782       734/841
(87 %)
46 diff
(94.6 %id)
BE168366 head_neck .d 324 to 727 408 to 6     Submitted on the opposite strand 403/408
(98 %)
0 diff
(100 %id)
AW362319 colon .d 345 to 795 11 to 461       451/475
(94 %)
15 diff
(96.9 %id)
CN346000 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 362 to 670 1 to 309       309/309
(100 %)
1 diff
(99.7 %id)
CX753679 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 379 to 742 1 to 364     Submitted on the opposite strand 364/707
(51 %)
2 diff
(99.8 %id)
BF961464 nervous_normal .d 411 to 793 1 to 383       383/383
(100 %)
12 diff
(96.9 %id)
AA365202 pineal body .d 418 to 678 1 to 261       261/261
(100 %)
0 diff
(100 %id)
F07042 brain, total brain .d 443 to 782 1 to 340       340/340
(100 %)
0 diff
(100 %id)
F07568 brain, total brain .d 443 to 783 1 to 341       341/341
(100 %)
0 diff
(100 %id)
F07569 brain, total brain .d 443 to 785 1 to 343       343/343
(100 %)
0 diff
(100 %id)
H72682 liver and spleen .d 444 to 812 1 to 371       371/371
(100 %)
2 diff
(99.5 %id)
BG743387 skin .d 498 to 1434 1 to 943       905/945
(95 %)
44 diff
(95.4 %id)
R13304 whole brain .d 501 to 866 1 to 372     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 372/388
(95 %)
9 diff
(97.7 %id)
R35808 whole brain .d 501 to 872 1 to 387       387/438
(88 %)
19 diff
(95.7 %id)
N33816 melanocyte .d 507 to 746 1 to 240       240/240
(100 %)
0 diff
(100 %id)
BM727759 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 529 to 1139 1 to 612   fully sequenced,   612/612
(100 %)
2 diff
(99.7 %id)
AA365102 pineal body .d 559 to 827 1 to 270       270/270
(100 %)
3 diff
(98.9 %id)
BE174455 head_neck .d 559 to 880 327 to 1     Submitted on the opposite strand 327/344
(95 %)
9 diff
(97.4 %id)
H10769 whole brain .d 564 to 1014 1 to 463       463/463
(100 %)
27 diff
(94.2 %id)
BX281154 adenocarcinoma, cell line, Prostate .d 573 to 1052 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BG253982 adenocarcinoma, cell line, Prostate .d 573 to 1258 1 to 687       687/819
(83 %)
10 diff
(98.8 %id)
DA303283 hippocampus .d 591 to 1183 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
CN345999 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 603 to 1283 1 to 682       682/682
(100 %)
6 diff
(99.2 %id)
BG178386 adenocarcinoma, cell line, Prostate .d 636 to 1457 1 to 812       812/911
(89 %)
41 diff
(95.5 %id)
BG025941 Bone, osteosarcoma, cell line .d 656 to 1408 1 to 744       744/930
(80 %)
14 diff
(98.5 %id)
AA091950   .d 662 to 973 1 to 306       306/310
(98 %)
23 diff
(92.6 %id)
AA383416 testis .d 671 to 1012 1 to 344       344/344
(100 %)
3 diff
(99.2 %id)
BM829932 stomach .d 685 to 1324 1 to 639       639/639
(100 %)
2 diff
(99.7 %id)
BF842071 head_neck .d 686 to 932 247 to 1     Submitted on the opposite strand 247/255
(96 %)
2 diff
(99.3 %id)
CD673910 eye, lens .d 686 to 1088 1 to 403       403/403
(100 %)
0 diff
(100 %id)
DB180802 kidney, tumor tissue .d 686 to 1244 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BM911999 amelanotic melanoma, cell line, skin .d 688 to 1283 1 to 597       597/1100
(54 %)
8 diff
(99.3 %id)
CF454303 peripheral nervous system .d 711 to 1473 1 to 763   tiling clone,   763/764
(99 %)
4 diff
(99.5 %id)
BG402752 bladder, transitional cell papilloma, cell line .d 726 to 1496 1 to 764       764/967
(79 %)
19 diff
(98.1 %id)
CX755424 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 783 to 1421 1 to 639     Submitted on the opposite strand 639/639
(100 %)
0 diff
(100 %id)
BQ345868 nervous_tumor .d 787 to 1070 1 to 288       288/299
(96 %)
18 diff
(94.0 %id)
CD518460 White Matter .d 795 to 1587 1 to 799       799/936
(85 %)
10 diff
(99.0 %id)
BG119256 adenocarcinoma, cell line, Liver .d 814 to 1567 1 to 748       748/986
(75 %)
15 diff
(98.5 %id)
BF961418 nervous_normal .d 875 to 1214 408 to 69       340/408
(83 %)
1 diff
(99.8 %id)
BF961416 nervous_normal .d 900 to 1269 370 to 1       370/370
(100 %)
10 diff
(97.3 %id)
BG029634 breast, mammary adenocarcinoma, cell line .d 901 to 1699 1 to 793       793/943
(84 %)
33 diff
(96.6 %id)
BM803164 duodenal adenocarcinoma, cell line, small intestine .d 903 to 1758 878 to 22   AAA Submitted on the opposite strand 857/1008
(85 %)
11 diff
(99.0 %id)
TI_149298692   .d 927 to 1755 902 to 85   AAA   818/957
(85 %)
14 diff
(98.6 %id)
CN346002 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 941 to 1522 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BG952339 colon .d 942 to 1069 156 to 28       129/161
(80 %)
7 diff
(95.7 %id)
BI022545 marrow .d 953 to 1341 401 to 7       395/402
(98 %)
24 diff
(94.1 %id)
DA386015 thalamus .d 957 to 1486 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BM450827 eye, retinoblastoma .d 965 to 1707 1 to 756       756/960
(78 %)
17 diff
(98.3 %id)
BF950756 nervous_normal .d 987 to 1497 16 to 524       509/524
(97 %)
10 diff
(98.1 %id)
BQ640047 eye, retina .d 999 to 1620 1 to 620       620/620
(100 %)
14 diff
(97.8 %id)
BM691890 eye, human retina .d 1003 to 1390 9 to 396   fully sequenced,   388/396
(97 %)
0 diff
(100 %id)
N95657 liver and spleen .d 1004 to 1319 1 to 316       316/316
(100 %)
5 diff
(98.5 %id)
BQ010700 placenta .d 1010 to 1351 368 to 27       342/376
(90 %)
0 diff
(100 %id)
TI_154128722   .d 1011 to 1743 814 to 84   AAA   731/731
(100 %)
4 diff
(99.5 %id)
CX784590 human embryonic stem cells .d 1017 to 1686 1 to 670       670/670
(100 %)
0 diff
(100 %id)
BM975402 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1042 to 1755 731 to 19   AAA   713/713
(100 %)
2 diff
(99.8 %id)
BQ345580 nervous_tumor .d 1045 to 1152 1 to 105       105/105
(100 %)
7 diff
(93.4 %id)
EL955453 eyeball .d 1051 to 1436 52 to 438       387/438
(88 %)
6 diff
(98.7 %id)
CX755729 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1068 to 1743 708 to 33   AAA Submitted on the opposite strand 676/700
(96 %)
15 diff
(97.9 %id)
BM459931 leiomyosarcoma, uterus .d 1070 to 1835 24 to 794       771/1043
(73 %)
36 diff
(96.6 %id)
AV701987 adrenal gland .d 1075 to 1758 1 to 678   AAA   678/678
(100 %)
13 diff
(98.1 %id)
N79875 multiple sclerosis lesions .d 1077 to 1367 1 to 292   fully sequenced,   292/292
(100 %)
10 diff
(96.6 %id)
CA444266 lung, Metastatic Chondrosarcoma .d 1086 to 1743 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
BU625782 cell lines, Enchondroma .d 1086 to 1755 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BG910249 anaplastic oligodendroglioma with 1p/19qloss, brain .d 1087 to 1744 50 to 705       656/720
(91 %)
13 diff
(98.2 %id)
BG255535 adenocarcinoma, cell line, Prostate .d 1096 to 1493 1 to 400       400/400
(100 %)
8 diff
(98.0 %id)
AL523442 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1099 to 1706 641 to 33       609/641
(95 %)
0 diff
(100 %id)
BM681404 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1109 to 1743 653 to 19   fully sequenced, AAA   635/635
(100 %)
3 diff
(99.6 %id)
CA417673 Chondrosarcoma Cell line .d 1118 to 1743 643 to 19   AAA   625/625
(100 %)
1 diff
(99.9 %id)
CA308704 Alveolar Macrophage, lung .d 1118 to 1748 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
BM719731 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1119 to 1270 1 to 152       152/168
(90 %)
1 diff
(99.5 %id)
BU690069 Human Lung Epithelial cells, lung .d 1120 to 1747 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
BF106232 lung .d 1141 to 1646 1 to 503       503/568
(88 %)
15 diff
(97.4 %id)
AW378486 head_neck .d 1142 to 1359 1 to 218       218/218
(100 %)
0 diff
(100 %id)
W63619 heart .d 1157 to 1743 583 to 1       583/584
(99 %)
10 diff
(98.3 %id)
BI753509 brain .d 1160 to 1642 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
TI_57218280   .d 1160 to 1642 53 to 535       483/535
(90 %)
6 diff
(98.9 %id)
AA024419 heart .d 1177 to 1663 1 to 495       495/496
(99 %)
22 diff
(95.6 %id)
BF476053 Prostate .d 1184 to 1744 563 to 3       561/563
(99 %)
0 diff
(100 %id)
CA430735 cell lines, Enchondroma .d 1188 to 1747 578 to 19   AAA   560/560
(100 %)
2 diff
(99.7 %id)
CX786270 human embryonic stem cells .d 1192 to 1748 593 to 37   AAA Submitted on the opposite strand 557/557
(100 %)
11 diff
(98.1 %id)
AA029982 uterus .d 1201 to 1425 1 to 234   fully sequenced,   234/234
(100 %)
1 diff
(99.6 %id)
AI001837   .d 1202 to 1338 150 to 15       136/150
(90 %)
0 diff
(100 %id)
AI991208 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 1208 to 1744 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
AW274451 Kidney .d 1208 to 1737 539 to 8       532/539
(98 %)
0 diff
(100 %id)
BF440047 brain, glioblastoma (pooled) .d 1208 to 1743 536 to 1       536/536
(100 %)
0 diff
(100 %id)
AW300114 Kidney .d 1209 to 1759 558 to 8       551/558
(98 %)
0 diff
(100 %id)
AI634542 carcinoid, lung .d 1212 to 1747 555 to 20   AAA   536/536
(100 %)
2 diff
(99.7 %id)
AI672402 Kidney .d 1213 to 1744 536 to 5       532/536
(99 %)
0 diff
(100 %id)
TI_157613887   .d 1215 to 1743 617 to 81   AAA   537/539
(99 %)
16 diff
(97.1 %id)
BG755808 B-cells, primary B-cells from tonsils (cell line) .d 1217 to 1755 1 to 546   available from MGC, AAA   546/546
(100 %)
16 diff
(97.1 %id)
BC015778 Primary B-Cells from Tonsils .d 1218 to 1755 1 to 538   available from MGC, AAA   538/538
(100 %)
1 diff
(99.9 %id)
AW664983 pooled .d 1219 to 1742 532 to 8       525/532
(98 %)
0 diff
(100 %id)
BF062023 pooled germ cell tumors .d 1219 to 1744 529 to 4       526/529
(99 %)
0 diff
(100 %id)
AW300127 Kidney .d 1220 to 1759 547 to 8       540/547
(98 %)
0 diff
(100 %id)
AI632484 pooled germ cell tumors .d 1226 to 1757 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
BE501517 Kidney .d 1229 to 1743 515 to 1       515/515
(100 %)
1 diff
(99.9 %id)
EC460746 Prostate .d 1231 to 1343 1 to 111       111/115
(96 %)
3 diff
(97.4 %id)
BE221787 Kidney .d 1232 to 1758 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
AI498167 anaplastic oligodendroglioma, brain .d 1238 to 1745 510 to 3       508/510
(99 %)
0 diff
(100 %id)
BP394495 pancreatic islet .d 1240 to 1738 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
AI672557 pooled germ cell tumors .d 1241 to 1758 532 to 15   AAA   518/518
(100 %)
3 diff
(99.5 %id)
BE326467 carcinoid, lung .d 1241 to 1748 526 to 19   AAA   508/508
(100 %)
7 diff
(98.7 %id)
CD358348 testis .d 1245 to 1758 8 to 522   AAA   515/522
(98 %)
10 diff
(98.1 %id)
BF886485 testis_normal .d 1257 to 1387 67 to 197       131/197
(66 %)
6 diff
(97.0 %id)
AW469508 pooled .d 1262 to 1686 1 to 425     Submitted on the opposite strand 425/425
(100 %)
2 diff
(99.6 %id)
DB572372 hypothalamus .d 1263 to 1746 1 to 485   AAA Submitted on the opposite strand 485/485
(100 %)
3 diff
(99.4 %id)
CA432013 cell lines, Enchondroma .d 1277 to 1743 485 to 19   AAA   467/492
(94 %)
3 diff
(99.4 %id)
AI659606 Prostate .d 1278 to 1744 469 to 3       467/469
(99 %)
0 diff
(100 %id)
AW006266 pooled germ cell tumors .d 1278 to 1744 469 to 3       467/469
(99 %)
0 diff
(100 %id)
TI_154104069   .d 1279 to 2236 1024 to 79   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 946/980
(96 %)
29 diff
(97.1 %id)
DA019785   .d 1280 to 1854 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB517311 testis .d 1282 to 1750 1 to 469     Submitted on the opposite strand 469/471
(99 %)
1 diff
(99.8 %id)
AW573189 pooled .d 1282 to 1745 1 to 463     Submitted on the opposite strand 463/463
(100 %)
2 diff
(99.6 %id)
AW665773 pooled .d 1282 to 1782 1 to 501     Submitted on the opposite strand 501/501
(100 %)
4 diff
(99.3 %id)
AW182579 pooled .d 1287 to 1832 1 to 546     Submitted on the opposite strand 546/546
(100 %)
3 diff
(99.5 %id)
AI862877 lymph node, lymphoma, follicular mixed small and largecell .d 1288 to 1748 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AW664939 pooled .d 1288 to 1759 475 to 4       472/475
(99 %)
0 diff
(100 %id)
DA653855   .d 1291 to 1842 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AA455715 germinal center B cell .d 1294 to 1739 1 to 442       442/442
(100 %)
7 diff
(98.5 %id)
AA459224 germinal center B cell .d 1294 to 1654 1 to 360       360/360
(100 %)
8 diff
(97.8 %id)
BP328604 rectum .d 1295 to 1874 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
AA669693 ovary .d 1299 to 1747 460 to 12   AAA   449/449
(100 %)
2 diff
(99.6 %id)
AA446051   .d 1300 to 1744 445 to 2     Submitted on the opposite strand 444/445
(99 %)
0 diff
(100 %id)
DB565667 hypothalamus .d 1301 to 1757 1 to 458     Submitted on the opposite strand 458/459
(99 %)
4 diff
(99.2 %id)
DB508848 testis .d 1304 to 1755 1 to 450     Submitted on the opposite strand 450/450
(100 %)
7 diff
(98.5 %id)
DB515540 testis .d 1309 to 1743 1 to 435     Submitted on the opposite strand 435/435
(100 %)
6 diff
(98.7 %id)
AW190461 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1310 to 1744 444 to 9       436/444
(98 %)
0 diff
(100 %id)
DB523622 testis .d 1312 to 1746 1 to 436     Submitted on the opposite strand 436/438
(99 %)
2 diff
(99.6 %id)
DB514293 testis .d 1316 to 1746 1 to 432     Submitted on the opposite strand 432/434
(99 %)
5 diff
(98.9 %id)
DB531572 hippocampus .d 1316 to 1757 1 to 442     Submitted on the opposite strand 442/442
(100 %)
1 diff
(99.8 %id)
DB526351 testis .d 1319 to 1755 1 to 437     Submitted on the opposite strand 437/437
(100 %)
2 diff
(99.6 %id)
AW197453 pooled germ cell tumors .d 1319 to 1747 438 to 10       429/438
(97 %)
0 diff
(100 %id)
H72683 liver and spleen .d 1329 to 1725 398 to 1       398/399
(99 %)
2 diff
(99.5 %id)
N66064 liver and spleen .d 1333 to 1756 431 to 4       428/431
(99 %)
0 diff
(100 %id)
N62971 multiple sclerosis lesions .d 1337 to 1758 421 to 1   fully sequenced,   421/421
(100 %)
3 diff
(99.3 %id)
DB508935 testis .d 1341 to 1755 1 to 416     Submitted on the opposite strand 416/416
(100 %)
3 diff
(99.3 %id)
DB335832 testis .d 1341 to 1754 420 to 1       420/426
(98 %)
9 diff
(97.9 %id)
BG249755 hypernephroma, cell line, Kidney .d 1349 to 1493 1 to 145       145/145
(100 %)
0 diff
(100 %id)
AI364520 anaplastic oligodendroglioma, brain .d 1350 to 1744 403 to 9       395/403
(98 %)
0 diff
(100 %id)
AI090733   .d 1355 to 1748 398 to 5       394/398
(98 %)
0 diff
(100 %id)
BM802988 duodenal adenocarcinoma, cell line, small intestine .d 1357 to 2241 928 to 41   AAA Submitted on the opposite strand 888/976
(90 %)
10 diff
(99.0 %id)
AA432293   .d 1359 to 1743 399 to 15   AAA   385/385
(100 %)
1 diff
(99.8 %id)
BU728592 eye, human retina .d 1360 to 1743 402 to 19   fully sequenced, AAA   384/384
(100 %)
0 diff
(100 %id)
AA719182 pineal gland .d 1367 to 1744 377 to 1       377/377
(100 %)
1 diff
(99.8 %id)
EC521966 Prostate .d 1372 to 1482 1 to 106       106/106
(100 %)
4 diff
(96.3 %id)
AA715091 germinal center B cell .d 1374 to 1676 1 to 302     Submitted on the opposite strand 302/302
(100 %)
10 diff
(96.7 %id)
AW205556   .d 1384 to 1743 377 to 18   AAA   360/367
(98 %)
2 diff
(99.5 %id)
CF528231 placenta .d 1384 to 1743 377 to 18   AAA   360/360
(100 %)
0 diff
(100 %id)
AA952896 pooled .d 1387 to 1744 360 to 3       358/360
(99 %)
0 diff
(100 %id)
AK024813   .d 1395 to 2236 1 to 842   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 842/842
(100 %)
0 diff
(100 %id)
BP207241 coronary artery .d 1395 to 1946 1 to 552       552/552
(100 %)
5 diff
(99.1 %id)
AA029847 uterus .d 1395 to 1758 366 to 1   fully sequenced,   366/366
(100 %)
2 diff
(99.5 %id)
AI122611 heart .d 1401 to 1744 350 to 7       344/350
(98 %)
0 diff
(100 %id)
BE140681 head_neck .d 1412 to 1581 1 to 168       168/172
(97 %)
10 diff
(94.2 %id)
BE044173 pooled .d 1442 to 1759 319 to 2       318/319
(99 %)
0 diff
(100 %id)
BF766303 colon_est .d 1450 to 1638 37 to 221       185/340
(54 %)
7 diff
(98.0 %id)
BE171075 head_neck .d 1455 to 1695 85 to 325       241/325
(74 %)
8 diff
(97.6 %id)
H10770 whole brain .d 1470 to 1759 295 to 3       293/295
(99 %)
0 diff
(100 %id)
AI921096 adenocarcinoma, Pancreas .d 1478 to 2240 759 to 4       756/767
(98 %)
0 diff
(100 %id)
CA446238 Chondrosarcoma, Left Pubic Bone .d 1486 to 2254 769 to 1       769/770
(99 %)
3 diff
(99.7 %id)
AV727003 hypothalamus .d 1496 to 1755 1 to 260   AAA   260/260
(100 %)
1 diff
(99.7 %id)
AV727526 hypothalamus .d 1496 to 1755 1 to 260   AAA   260/260
(100 %)
1 diff
(99.7 %id)
CN345998 embryonic stem cells, DMSO-treated H9 cellline .d 1497 to 2184 1 to 688       688/688
(100 %)
0 diff
(100 %id)
AW593191 pooled .d 1505 to 1744 242 to 3       240/242
(99 %)
0 diff
(100 %id)
CA429565 Cell Line, Chondrosarcoma .d 1519 to 2227 726 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 708/708
(100 %)
7 diff
(99.1 %id)
AI368524 anaplastic oligodendroglioma, brain .d 1547 to 1748 212 to 11   AAA   202/202
(100 %)
0 diff
(100 %id)
AI935327 Kidney .d 1556 to 1743 219 to 32   AAA   188/188
(100 %)
9 diff
(95.3 %id)
AA780265   .d 1560 to 2240 681 to 1       681/681
(100 %)
1 diff
(99.9 %id)
EC542013 Prostate .d 1607 to 1715 12 to 117       106/117
(90 %)
6 diff
(94.9 %id)
BU628050 Bone, Enchondroma cell line .d 1614 to 2254 641 to 1       641/641
(100 %)
3 diff
(99.6 %id)
AW968418   .d 1619 to 2226 613 to 1     Submitted on the opposite strand 613/618
(99 %)
20 diff
(96.8 %id)
BF196618 brain, glioblastoma (pooled) .d 1619 to 1758 140 to 1       140/140
(100 %)
1 diff
(99.3 %id)
CX760793 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1620 to 2240 621 to 3       619/704
(87 %)
0 diff
(100 %id)
CD107030 brain, Pituitary .d 1638 to 2236 1 to 599       599/600
(99 %)
2 diff
(99.7 %id)
CA435159 lung, Lung Focal Fibrosis .d 1640 to 2251 1 to 608   AAA Submitted on the opposite strand 608/620
(98 %)
9 diff
(98.6 %id)
BE222612 brain, oligodendroglioma .d 1648 to 2139 1 to 492     Submitted on the opposite strand 492/492
(100 %)
2 diff
(99.6 %id)
AI870510 anaplastic oligodendroglioma, brain .d 1659 to 2127 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
BE613544 leiomyosarcoma, uterus .d 1663 to 2350 1 to 685       685/689
(99 %)
16 diff
(97.7 %id)
AV713510   .d 1677 to 2394 1 to 719       719/719
(100 %)
11 diff
(98.5 %id)
BM929390 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1680 to 2010 11 to 341   AAA   331/341
(97 %)
7 diff
(98.0 %id)
AI681695 carcinoid, lung .d 1693 to 2235 543 to 1       543/543
(100 %)
0 diff
(100 %id)
AI912594 carcinoid, lung .d 1693 to 2239 547 to 1       547/547
(100 %)
0 diff
(100 %id)
BE218244 carcinoid, lung .d 1705 to 2239 535 to 1       535/535
(100 %)
0 diff
(100 %id)
BI836894 pooled pancreas and spleen .d 1707 to 2436 1 to 732       732/732
(100 %)
12 diff
(98.4 %id)
TI_57163753   .d 1707 to 2436 78 to 809       732/809
(90 %)
6 diff
(99.3 %id)
BI756837 brain .d 1714 to 2525 1 to 814       814/981
(82 %)
27 diff
(97.3 %id)
TI_57220085   .d 1715 to 2525 63 to 875       813/1042
(78 %)
27 diff
(97.5 %id)
AA829864 germinal center B cell .d 1717 to 2236 529 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 519/519
(100 %)
3 diff
(99.5 %id)
AI921108 adenocarcinoma, Pancreas .d 1718 to 2240 526 to 4       523/526
(99 %)
0 diff
(100 %id)
FN174729 breast carcinoma .d 1719 to 1814 95 to 1     Submitted on the opposite strand 95/95
(100 %)
5 diff
(94.8 %id)
BI761803 pooled colon, kidney, stomach .d 1723 to 1776 654 to 712       502/717
(70 %)
28 diff
(96.1 %id)
BE222037 carcinoid, lung .d 1726 to 2239 514 to 1       514/514
(100 %)
0 diff
(100 %id)
AW273778 lung, two pooled squamous cell carcinomas .d 1727 to 2242 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BE550430 pooled germ cell tumors .d 1728 to 2236 509 to 1       509/509
(100 %)
1 diff
(99.9 %id)
BQ000704 Fibrosarcoma .d 1747 to 2255 511 to 3       509/519
(98 %)
0 diff
(100 %id)
AI368759 lung .d 1748 to 2236 489 to 1       489/489
(100 %)
2 diff
(99.6 %id)
AA455660 germinal center B cell .d 1756 to 2236 481 to 1       481/484
(99 %)
0 diff
(100 %id)
BF435798 pooled .d 1757 to 2239 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BU508319 leiomyosarcoma, uterus .d 1771 to 2516 1 to 751       751/947
(79 %)
12 diff
(98.8 %id)
N24939.
matches multiple genes
melanocyte .d 1772 to 2236 464 to 1     also hits gene SFT2D2andTBX19 464/464
(100 %)
1 diff
(99.8 %id)
AA972594 pooled .d 1772 to 2236 465 to 1       465/465
(100 %)
0 diff
(100 %id)
BE875609 large cell carcinoma, undifferentiated, lung .d 1774 to 2506 1 to 732       732/915
(80 %)
30 diff
(96.8 %id)
AI936847 anaplastic oligodendroglioma, brain .d 1778 to 2237 462 to 3       460/462
(99 %)
0 diff
(100 %id)
CN295311 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1779 to 2354 13 to 588       576/588
(97 %)
6 diff
(99.0 %id)
AW003963 pooled germ cell tumors .d 1779 to 2236 459 to 1       459/459
(100 %)
7 diff
(98.5 %id)
AA548971 germ cell tumor .d 1781 to 2237 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AA602625 adrenal adenoma, adrenal gland .d 1782 to 2237 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AA845904 Spleen .d 1782 to 2227 457 to 12   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
BE677680 dorsal root ganglia .d 1787 to 2242 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
AI130979 heart .d 1796 to 2238 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI440191 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1801 to 2241 441 to 1       441/441
(100 %)
6 diff
(98.7 %id)
AI351669   .d 1802 to 2239 439 to 1       439/439
(100 %)
3 diff
(99.4 %id)
BE326451 carcinoid, lung .d 1802 to 2240 443 to 5       439/443
(99 %)
0 diff
(100 %id)
BE677639 dorsal root ganglia .d 1823 to 2242 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW138315   .d 1829 to 1981 1 to 153     Submitted on the opposite strand 153/153
(100 %)
5 diff
(96.8 %id)
AA459005 germinal center B cell .d 1831 to 2236 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AA524204 colon .d 1834 to 2236 404 to 1       404/471
(85 %)
1 diff
(99.8 %id)
AI302146 carcinoid, lung .d 1840 to 2239 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA459004 germinal center B cell .d 1841 to 2071 231 to 1       231/231
(100 %)
1 diff
(99.6 %id)
BF477898 carcinoid, lung .d 1846 to 2221 1 to 376     Submitted on the opposite strand 376/376
(100 %)
0 diff
(100 %id)
AI214579 carcinoid, lung .d 1849 to 2199 1 to 351     Submitted on the opposite strand 351/351
(100 %)
1 diff
(99.8 %id)
BM855475 Ascites, stomach .d 1849 to 2257 410 to 2     Submitted on the opposite strand 409/410
(99 %)
0 diff
(100 %id)
AI912153 carcinoid, lung .d 1850 to 2222 1 to 373     Submitted on the opposite strand 373/373
(100 %)
0 diff
(100 %id)
AI694799 carcinoid, lung .d 1851 to 2199 1 to 349     Submitted on the opposite strand 349/349
(100 %)
1 diff
(99.8 %id)
BE467840 carcinoid, lung .d 1851 to 2199 1 to 349     Submitted on the opposite strand 349/349
(100 %)
0 diff
(100 %id)
BE467918 carcinoid, lung .d 1851 to 2199 1 to 349     Submitted on the opposite strand 349/349
(100 %)
0 diff
(100 %id)
BE467937 carcinoid, lung .d 1851 to 2199 1 to 349     Submitted on the opposite strand 349/349
(100 %)
0 diff
(100 %id)
BE503208 carcinoid, lung .d 1851 to 2199 1 to 349     Submitted on the opposite strand 349/349
(100 %)
0 diff
(100 %id)
AA723573 parathyroid gland, parathyroid tumor .d 1853 to 2203 1 to 351     Submitted on the opposite strand 351/351
(100 %)
0 diff
(100 %id)
AI091461 pooled .d 1853 to 2203 1 to 351     Submitted on the opposite strand 351/351
(100 %)
0 diff
(100 %id)
AA024420 heart .d 1861 to 2227 375 to 1       375/428
(87 %)
9 diff
(97.9 %id)
AU311603 neuroblastoma .d 1874 to 2413 1 to 540       540/540
(100 %)
0 diff
(100 %id)
AI188357 placenta .d 1881 to 2218 353 to 16       338/353
(95 %)
0 diff
(100 %id)
BQ024595 placenta .d 1881 to 2227 365 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 347/347
(100 %)
4 diff
(98.9 %id)
AI572175 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1889 to 2236 349 to 1       349/351
(99 %)
3 diff
(99.2 %id)
AA927127 pooled .d 1890 to 2239 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AA975509 pooled .d 1893 to 2239 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AW470259 carcinoid, lung .d 1918 to 2239 323 to 1       323/333
(96 %)
3 diff
(99.1 %id)
AW023248 cochlea, ear .d 1921 to 2236 1 to 316   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 316/316
(100 %)
5 diff
(98.5 %id)
T16805   .d 1925 to 2234 313 to 4       310/313
(99 %)
0 diff
(100 %id)
CA450205 Human Lung Epithelial cells, lung .d 1929 to 2254 326 to 1       326/334
(97 %)
2 diff
(99.5 %id)
CA313984 Human Lung Epithelial cells, lung .d 1929 to 2254 326 to 1       326/334
(97 %)
2 diff
(99.5 %id)
CN295310 embryonic stem cells, DMSO-treated H9 cellline .d 1931 to 2611 1 to 682       682/682
(100 %)
2 diff
(99.8 %id)
AI473134 Kidney .d 1936 to 2236 301 to 1       301/301
(100 %)
0 diff
(100 %id)
BG899475 cartilage .d 1937 to 2185 180 to 428       249/360
(69 %)
6 diff
(98.4 %id)
AI341595 pooled germ cell tumors .d 1938 to 2213 12 to 287     Submitted on the opposite strand 276/287
(96 %)
6 diff
(98.0 %id)
AI383106 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1943 to 2239 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AA988155 carcinoid, lung .d 1947 to 2236 290 to 1       290/290
(100 %)
0 diff
(100 %id)
BE327758 carcinoid, lung .d 1951 to 2238 288 to 1       288/288
(100 %)
0 diff
(100 %id)
AI308071 2 pooled tumors (clear cell type), Kidney .d 1953 to 2353 424 to 24   AAA   401/410
(97 %)
0 diff
(100 %id)
BG928583 cartilage .d 1958 to 2485 86 to 613       528/545
(96 %)
6 diff
(98.9 %id)
R40787 whole brain .d 1960 to 2236 297 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 287/287
(100 %)
11 diff
(96.2 %id)
AA906253 pooled .d 1963 to 2236 274 to 1       274/274
(100 %)
0 diff
(100 %id)
BG898413 cartilage .d 1964 to 2295 108 to 439       332/370
(89 %)
6 diff
(98.4 %id)
AI918795 pooled germ cell tumors .d 1964 to 2213 1 to 250     Submitted on the opposite strand 250/250
(100 %)
1 diff
(99.6 %id)
BM930423 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1966 to 2240 278 to 4     Submitted on the opposite strand 275/285
(96 %)
0 diff
(100 %id)
Z40617 brain, total brain .d 1970 to 2236 267 to 1       267/267
(100 %)
0 diff
(100 %id)
AA906256 pooled .d 1971 to 2217 247 to 1       247/247
(100 %)
1 diff
(99.6 %id)
AA907736 pooled .d 1971 to 2218 248 to 1       248/248
(100 %)
1 diff
(99.6 %id)
AW274013 pooled .d 1971 to 2218 248 to 1       248/248
(100 %)
0 diff
(100 %id)
AW274023 pooled .d 1971 to 2218 248 to 1       248/248
(100 %)
0 diff
(100 %id)
F04896 brain, total brain .d 1974 to 2236 263 to 1       263/263
(100 %)
1 diff
(99.7 %id)
T98193 liver and spleen .d 1976 to 2237 1 to 261     Submitted on the opposite strand 261/462
(56 %)
2 diff
(99.6 %id)
AA203543 liver and spleen .d 1976 to 2236 261 to 1     Submitted on the opposite strand 261/261
(100 %)
0 diff
(100 %id)
T98192 liver and spleen .d 1977 to 2237 262 to 1     Submitted on the opposite strand 262/269
(97 %)
1 diff
(99.7 %id)
AA700917 liver and spleen .d 1977 to 2203 1 to 227     Submitted on the opposite strand 227/227
(100 %)
0 diff
(100 %id)
AI917021 pooled germ cell tumors .d 1977 to 2213 1 to 237     Submitted on the opposite strand 237/237
(100 %)
0 diff
(100 %id)
AI611116 pooled germ cell tumors .d 1977 to 2227 1 to 251   AAA Submitted on the opposite strand 251/251
(100 %)
0 diff
(100 %id)
AI638777 pooled germ cell tumors .d 1977 to 2213 1 to 237     Submitted on the opposite strand 237/237
(100 %)
0 diff
(100 %id)
BF223495 pooled germ cell tumors .d 1977 to 2213 1 to 237     Submitted on the opposite strand 237/237
(100 %)
0 diff
(100 %id)
AI696191 pooled germ cell tumors .d 1978 to 2227 1 to 249   AAA Submitted on the opposite strand 249/249
(100 %)
1 diff
(99.6 %id)
AI692608 carcinoid, lung .d 1978 to 2216 1 to 239     Submitted on the opposite strand 239/239
(100 %)
1 diff
(99.6 %id)
BE219550 carcinoid, lung .d 1984 to 2223 1 to 240     Submitted on the opposite strand 240/240
(100 %)
0 diff
(100 %id)
BE326255 carcinoid, lung .d 1984 to 2223 1 to 240     Submitted on the opposite strand 240/240
(100 %)
2 diff
(99.2 %id)
T17433   .d 1993 to 2236 244 to 1       244/244
(100 %)
0 diff
(100 %id)
AW089288 brain, tumor, 5 pooled (see description) .d 2004 to 2241 238 to 1       238/238
(100 %)
0 diff
(100 %id)
BF792024 adrenal cortex carcinoma, cell line, adrenal gland .d 2020 to 2362 1 to 344   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 344/344
(100 %)
1 diff
(99.8 %id)
AI873204 pooled .d 2038 to 2236 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AW467932 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d 2040 to 2241 203 to 1       203/203
(100 %)
1 diff
(99.6 %id)
AA904804 pooled .d 2058 to 2236 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
AA927938 pooled .d 2065 to 2236 172 to 1       172/172
(100 %)
0 diff
(100 %id)
AA724749 pooled .d 2124 to 2236 113 to 1       113/113
(100 %)
0 diff
(100 %id)
CN295312 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 2164 to 2607 1 to 447       447/447
(100 %)
4 diff
(99.2 %id)
BF438035 carcinoid, lung .d 2192 to 2716 1 to 527     Submitted on the opposite strand 527/527
(100 %)
2 diff
(99.7 %id)
AA301109 testis .d 2193 to 2397 13 to 217       205/217
(94 %)
6 diff
(97.3 %id)
BM465690 lymph, lymphoma, cell line .d 2201 to 3055 1 to 865   tiling clone,   865/1133
(76 %)
32 diff
(97.2 %id)
AA034991 uterus .d 2211 to 2582 1 to 375       375/375
(100 %)
3 diff
(99.2 %id)
DA681301 ovary .d 2212 to 2677 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
BX112686 uterus .d 2219 to 2841 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
AA143030 uterus .d 2219 to 2705 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
BU675909 lung, Primary Lung Epithelial Cells .d 2223 to 2889 14 to 680   AAA Submitted on the opposite strand 667/680
(98 %)
0 diff
(100 %id)
BG539291 lung .d 2276 to 2977 1 to 702       702/855
(82 %)
15 diff
(98.3 %id)
DN916786   .d 2280 to 2934 1 to 648       648/658
(98 %)
11 diff
(98.4 %id)
AA044981 eye, retina .d 2297 to 2661 1 to 368       368/388
(94 %)
9 diff
(97.7 %id)
W37092 parathyroid gland, parathyroid tumor .d 2305 to 2671 1 to 372       372/454
(81 %)
7 diff
(98.5 %id)
T33969 blood, white blood cells .d 2309 to 2683 1 to 379       379/387
(97 %)
15 diff
(96.2 %id)
BM685821 eye, Retina Foveal and Macular .d 2314 to 2947 1 to 634     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 634/634
(100 %)
9 diff
(98.6 %id)
Z43451 brain, total brain .d 2319 to 2577 1 to 259       259/259
(100 %)
5 diff
(98.1 %id)
N44714 melanocyte .d 2319 to 2590 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
BM693183 eye, Retina Foveal and Macular .d 2320 to 2925 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM729256 eye, fetal eye .d 2322 to 2914 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
DR421758 eye, Pterygium .d 2324 to 2887 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
N99439 melanocyte .d 2327 to 2607 1 to 282       282/282
(100 %)
2 diff
(99.3 %id)
AA281192 germinal center B cell .d 2327 to 2590 1 to 264     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 264/269
(98 %)
1 diff
(99.7 %id)
AA399960   .d 2327 to 2879 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AA293010 ovarian tumor, ovary .d 2328 to 2752 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
BG912411 anaplastic oligodendroglioma with 1p/19qloss, brain .d 2328 to 3000 1 to 674       674/674
(100 %)
3 diff
(99.6 %id)
BP423712 small intestine .d 2332 to 2872 1 to 541     Submitted on the opposite strand 541/541
(100 %)
0 diff
(100 %id)
AA281067 germinal center B cell .d 2835 to 3268 450 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 434/434
(100 %)
0 diff
(100 %id)
W44772 parathyroid gland, parathyroid tumor .d 2865 to 3340 478 to 1       478/478
(100 %)
2 diff
(99.6 %id)
AA150983 uterus .d 2943 to 3334 394 to 1       394/394
(100 %)
4 diff
(99.0 %id)
N35346 melanocyte .d 2956 to 3334 382 to 1       382/382
(100 %)
4 diff
(99.0 %id)
AA399292 ovarian tumor, ovary .d 2976 to 3335 360 to 1       360/360
(100 %)
0 diff
(100 %id)
N72004 melanocyte .d 3057 to 3334 278 to 1       278/285
(97 %)
3 diff
(99.0 %id)
AU311604 neuroblastoma .d 3225 to 3809 599 to 16       584/599
(97 %)
0 diff
(100 %id)
DB322541 ovary .d 3252 to 3808 557 to 1   tiling clone,   557/557
(100 %)
0 diff
(100 %id)
BU726191 eye, Retina Foveal and Macular .d 3284 to 3809 543 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
Z39527 brain, total brain .d 3551 to 3809 259 to 1       259/259
(100 %)
0 diff
(100 %id)
DB024293 testis .e 1 to 554 2 to 555   tiling clone, capped   554/554
(100 %)
2 diff
(99.7 %id)
BG189105   .e 364 to 1062 1 to 700   tiling clone,   700/729
(96 %)
32 diff
(95.7 %id)
DR006505 Spleen .f 1 to 716 1 to 715 exact tiling clone,   715/715
(100 %)
9 diff
(98.8 %id)
AK303283 thymus .g 1 to 1380 1 to 1380 exact tiling clone,   1380/1380
(100 %)
2 diff
(99.9 %id)
DC407616 thymus .g 1 to 542 1 to 543       543/543
(100 %)
3 diff
(99.5 %id)
H17376 whole brain .h 1 to 642 1 to 634   tiling clone,   634/636
(99 %)
21 diff
(96.7 %id)
H18069 whole brain .h 709 to 1240 550 to 18   tiling clone,   533/550
(96 %)
0 diff
(100 %id)
DB051529 testis .i 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BM852051 stomach .i 512 to 994 1 to 483   tiling clone,   483/483
(100 %)
4 diff
(99.2 %id)
BI828637 brain, medulla .j 1 to 864 1 to 863 P112Q E113S Q114R A132V E133N ... tiling clone,   863/867
(99 %)
5 diff
(99.5 %id)
TI_57175337   .j 1 to 864 31 to 893 P112Q E113S Q114R A132V E133N ...     863/897
(96 %)
11 diff
(98.8 %id)
BG773097 testis .k 1 to 754 6 to 759   tiling clone,   759/761
(99 %)
8 diff
(99.0 %id)
DB039889 testis .k 1 to 349 2 to 350   tiling clone, capped   349/569
(61 %)
1 diff
(99.9 %id)
DB028252 testis .k 2 to 323 2 to 323   capped   322/546
(58 %)
2 diff
(99.7 %id)
DB036753 testis .k 2 to 323 2 to 324   capped   323/575
(56 %)
5 diff
(99.2 %id)
BG771967 testis .k 5 to 840 6 to 834   tiling clone,   829/837
(99 %)
18 diff
(97.9 %id)
DB050206 testis .k 6 to 349 2 to 345   capped   344/569
(60 %)
1 diff
(99.9 %id)
DB051098 testis .k 10 to 349 2 to 342   capped   341/561
(60 %)
2 diff
(99.7 %id)
TI_57172394   .k 11 to 350 27 to 366       340/822
(41 %)
7 diff
(99.2 %id)
DB047374 testis .k 11 to 349 2 to 340   capped   339/572
(59 %)
0 diff
(100 %id)
DB041184 testis .k 17 to 349 2 to 334   capped   333/560
(59 %)
0 diff
(100 %id)
DB037034 testis .l 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
BG721511 testis .l 44 to 816 1 to 773 F91L H110T P112Q E113S Q114R ... tiling clone,   773/777
(99 %)
12 diff
(98.5 %id)
DB047508 testis .l 45 to 583 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DB053875 testis .l 46 to 599 2 to 555   capped   554/555
(99 %)
0 diff
(100 %id)
DB027803 testis .l 49 to 647 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DB047980 testis .l 50 to 606 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DC398780 testis .m 1 to 566 1 to 566 exact tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
DC398444 testis .n 1 to 585 1 to 586 exact tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
DB034887 testis .o 1 to 565 7 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DB056567 testis .o 22 to 514 2 to 494   capped   493/493
(100 %)
0 diff
(100 %id)
BI831644 brain, medulla .o 338 to 697 335 to 703 Q13L L21W V22F F23L T24P ... tiling clone,   369/793
(46 %)
26 diff
(96.8 %id)
BX954911   .p 1 to 501 1 to 501 exact tiling clone,   501/501
(100 %)
0 diff
(100 %id)
CN346001 embryonic stem cells, DMSO-treated H9 cellline .q 1 to 401 1 to 401 exact tiling clone,   401/401
(100 %)
0 diff
(100 %id)
AI243525 pooled .r -11 to 375 390 to 3 exact tiling clone,   388/402
(96 %)
5 diff
(98.8 %id)
T83890 liver and spleen .s-u 1 to 401 1 to 408 P12L V13F P21X R22G T23R ... tiling clone,   408/408
(100 %)
24 diff
(94.2 %id)
T83721 liver and spleen .s-u 1089 to 1412 326 to 1   tiling clone,   326/326
(100 %)
3 diff
(99.1 %id)
BG772591 testis .t 1 to 527 2 to 528   tiling clone,   528/805
(65 %)
6 diff
(99.3 %id)
DB449270 testis .t 5 to 428 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
DB458140 testis .t 5 to 496 1 to 492       492/492
(100 %)
0 diff
(100 %id)
DB040966 testis .t 6 to 562 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
DC399614 testis .t 543 to 1086 1 to 544 exact tiling clone,   544/544
(100 %)
0 diff
(100 %id)
BG722860 testis .u 1 to 746 2 to 749 R27T K28Q S29E L30S F31L ... tiling clone,   749/749
(100 %)
13 diff
(98.3 %id)
CD358550 testis .va 1 to 743 5 to 750 K43E Y44I S45Q S46F C47P ... tiling clone,   750/847
(88 %)
18 diff
(97.9 %id)
BU853829 testis .vb-u 1 to 523 1 to 531 exact tiling clone,   531/786
(67 %)
29 diff
(96.4 %id)
BE972793 testis .vb-u 24 to 547 1 to 520   tiling clone,   520/707
(73 %)
30 diff
(95.8 %id)
DB027451 testis .vc 1 to 592 2 to 593 exact tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
CV426268 stomach .vd-u 1 to 519 31 to 548 K2Q P3A L14V G16D I24S ...     518/548
(94 %)
15 diff
(97.3 %id)
AW820657 stomach .vd-u 9 to 557 19 to 567   tiling clone,   549/567
(96 %)
6 diff
(99.0 %id)
AW820678 stomach .vd-u 18 to 583 1 to 566   tiling clone,   566/567
(99 %)
3 diff
(99.5 %id)
AW820682 stomach .vd-u 18 to 575 1 to 559   tiling clone,   559/559
(100 %)
6 diff
(99.0 %id)
DB034425 testis .ve 1 to 568 2 to 569 exact tiling clone, capped   568/570
(99 %)
1 diff
(99.9 %id)
DB038347 testis .ve 2 to 568 2 to 568 exact capped   567/567
(100 %)
1 diff
(99.9 %id)
DB443913 testis .vf 1 to 448 5 to 454 exact tiling clone,   454/454
(100 %)
3 diff
(99.4 %id)
DB444029 testis .vf 1 to 444 5 to 448 exact tiling clone,   448/448
(100 %)
2 diff
(99.6 %id)
DB048229 testis .vg 1 to 415 2 to 416 exact tiling clone, capped   415/562
(73 %)
1 diff
(99.9 %id)
BI037441 nervous_tumor .vh-u 1 to 312 314 to 4 K2I L4W A5P F23L tiling clone,   311/315
(98 %)
0 diff
(100 %id)
BI040793 nervous_tumor .vh-u 7 to 302 25 to 319   tiling clone,   295/335
(88 %)
6 diff
(98.3 %id)
AA383283 testis Gene CCNY, variant not shown         This clone was ignored    
AF465728   Gene CCNY, variant not shown       AAA This clone was ignored    
AJ705726 bone marrow Gene CCNY, variant not shown         Suspected internal deletion, this clone was ignored    
AK314666 uterus Gene CCNY, variant not shown         Suspected internal deletion, this clone was ignored    
AW887602 ovary Gene CCNY, variant not shown         This clone was ignored    
DB304393 brain Gene CCNY, variant not shown         This clone was ignored    
DA211018 brain Gene CCNY, variant not shown       capped This clone was ignored    
DB311599 thalamus Gene CCNY, variant not shown         This clone was ignored    
DA384822 thalamus Gene CCNY, variant not shown       capped This clone was ignored    
AV714959   Gene CCNY, variant not shown         Suspected internal deletion, this clone was ignored    
AA278458 germinal center B cell Gene CCNY, variant not shown         Submitted on the opposite strand    
AA476431.
matches multiple genes
  Gene ganyby, variant not shown         This clone was ignored, also hits gene ganyby    
AA476431.
matches multiple genes
  Gene CCNY, variant not shown         This clone was ignored, also hits gene ganyby    
AA476536.
matches multiple genes
  Gene ganyby, variant not shown         This clone was ignored, also hits gene ganyby    
AA476536.
matches multiple genes
  Gene CCNY, variant not shown         This clone was ignored, also hits gene ganyby    
AI168162 pooled Gene CCNY, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI027367 parathyroid gland, parathyroid tumor Gene CCNY, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI339270 pooled germ cell tumors Gene CCNY, variant not shown       AAA This clone was ignored    
AI392880 B-cell, chronic lymphotic leukemia Gene CCNY, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI631939 Kidney Gene CCNY, variant not shown         This clone was ignored    
AI971599 pooled germ cell tumors Gene CCNY, variant not shown       AAA This clone was ignored    
AI989522 pooled germ cell tumors Gene CCNY, variant not shown         This clone was ignored    
BU852339 testis Gene CCNY, variant not shown              
N56479   Gene CCNY, variant not shown         Suspected internal deletion, this clone was ignored    
DB264089 uterus Gene CCNY, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t, .u, .va, .vb-u, .vc, .vd-u, .ve, .vf, .vg, .vh-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI